Company / Capital Expenditures
Zymeworks Inc. Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$1.5M
FY2025
5-year range
$1.5M / $12.4M
FY2021-FY2025
Trend
-23.6%
vs FY2024
Sector context
#102 of 194
Health Care
What the data says
At $2M, Zymeworks Inc.'s capital expenditures ranks #102 of 194 in the Health Care sector. Capital Expenditures has declined for 4 consecutive years, from $12M in FY2021 to $2M in FY2025.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of -18.8%.
Declined from $2M to $2M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -29.3%
- 5-Year CAGR
- -18.8%
- 10-Year CAGR
- -
Sector benchmark
#102 of 194 in Health CareTop 53% of 194This company $1.5M Sector average $117.5M
▼
-98.7% below sector average
Key checks
Key Insights
- Zymeworks Inc.'s capital expenditures has declined for 4 consecutive years.
- 5-year CAGR of -18.8%, indicating a declining trend.
- In FY2025, capital expenditures decreased 23.6% year-over-year.
- Ranks #102 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.5M | -23.6% |
| FY2024 | $2.0M | -19.5% |
| FY2023 | $2.5M | -42.6% |
| FY2022 | $4.3M | -65.3% |
| FY2021 | $12.4M | +187.8% |
| FY2020 | $4.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026